EK

Eric Kersi Tangri

Active Director Director DIN 07428281
DIN 07428281 First appointment Oct 2016 Primary industry Manufacturing
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Oct 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Eric Kersi Tangri

Data last updated:

Eric Kersi Tangri is a Director at Avesta Pharma Private Limited (since 2024), Designated Partner at Hildose Pharmaspecialities Llp (since 2020) and Designated Partner at Enkad Trading Llp (since 2016). The companies operate in Manufacturing, Pharma and Business Services. The largest current company by reported revenue is Avesta Pharma Private Limited at ₹202 Cr (FY 2025). Earlier, Eric Kersi Tangri was a Director at Hildose Pharma Private Limited (2019–2020).

DIN 07428281
Primary Designation Director
Industry Manufacturing
First Appointment 16 Oct 2016
Oldest Company Age 17 yrs
Largest company Avesta Pharma Private Limited Β· ₹202 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avesta Pharma Private Limited U24239MH2009PTC192677
Director01 Mar 20242009₹202 Cr (FY 2025)Active
Designated Partner12 Feb 20202020Active
Designated Partner16 Oct 20162016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hildose Pharma Private Limited U24233MH2012PTC239076
Director19 Mar 20192012Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hildose Pharmaspecialities Llp
Enkad Trading Llp
Avesta Pharma Private Limited
Hildose Pharma Private Limited
Premium access

Shareholding and investment profile for Eric Kersi Tangri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Eric Kersi Tangri

Eric Kersi Tangri currently holds 3 directorships: Avesta Pharma Private Limited (Director, since 01 Mar 2024, revenue β‚Ή202 Cr (FY 2025)); Hildose Pharmaspecialities Llp (Designated Partner, since 12 Feb 2020); Enkad Trading Llp (Designated Partner, since 16 Oct 2016).

Eric Kersi Tangri was first appointed on 16 Oct 2016 as Designated Partner at Enkad Trading Llp. The most recent appointment on record is 01 Mar 2024 at Avesta Pharma Private Limited.

Eric Kersi Tangri held 1 earlier board appointment: Hildose Pharma Private Limited (Director, 19 Mar 2019 to 11 Feb 2020).

The current boards of Eric Kersi Tangri's companies include Amol Ashok Walke (Avesta Pharma Private Limited), Kersi Homi Tangri (Avesta Pharma Private Limited), Mahesh Hakmichand Doshi (Avesta Pharma Private Limited), Zubin Keki Gandhi (Avesta Pharma Private Limited), Karl Kersi Tangri (Hildose Pharmaspecialities Llp), Niraj Mahesh Doshi (Enkad Trading Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available